REGENXBIO Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
/ 
Frequently asked questions
To buy REGENXBIO Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for REGENXBIO Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for REGENXBIO Inc. is RGNX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
REGENXBIO Inc. has its primary listing on NASDAQ. You can trade REGENXBIO Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, REGENXBIO Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include REGENXBIO Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like REGENXBIO Inc. or others.